The present invention provides for {HEAD ~ a pharmaceutical composition} comprising {TAIL ~ a therapeutically effect amount} of an isolated peptide having an amino acid sequence corresponding to the amino acid sequence of a V domain of RAGE 
The present invention provides for { HEAD ~ a pharmaceutical composition } comprising { TAIL ~ a therapeutically effect amount } of an isolated peptide having an amino acid sequence corresponding to the amino acid sequence of a V domain of RAGE
OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH